NDSI
CVS icon

Newman Dignan & Sheerar Inc’s CVS Health CVS Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
10,424
-25
-0.2% -$2.23K 0.21% 83
2026
Q1 		$750K Sell
10,449
-681
-6% -$52.5K 0.16% 99
2025
Q4 		$883K Buy
11,130
+2,258
+25% +$178K 0.18% 97
2025
Q3 		$669K Sell
8,872
-192
-2% -$13.2K 0.14% 108
2025
Q2 		$625K Sell
9,064
-295
-3% -$19.3K 0.14% 108
2025
Q1 		$634K Sell
9,359
-358
-4% -$21.4K 0.17% 96
2024
Q4 		$436K Sell
9,717
-896
-8% -$50.3K 0.11% 115
2024
Q3 		$609K Sell
10,613
-6,659
-39% -$388K 0.15% 105
2024
Q2 		$1.02M Sell
17,272
-2,462
-12% -$154K 0.26% 80
2024
Q1 		$1.57M Sell
19,734
-2,668
-12% -$204K 0.42% 61
2023
Q4 		$1.77M Buy
22,402
+535
+2% +$38.1K 0.53% 51
2023
Q3 		$1.53M Sell
21,867
-2,207
-9% -$156K 0.5% 53
2023
Q2 		$1.66M Buy
24,074
+441
+2% +$31.4K 0.51% 57
2023
Q1 		$1.76M Sell
23,633
-1,758
-7% -$147K 0.56% 50
2022
Q4 		$2.37M Buy
25,391
+57
+0.2% +$5.5K 0.78% 40
2022
Q3 		$2.42K Buy
25,334
+126
+0.5% +$12.5K 0.38% 36
2022
Q2 		$2.34M Sell
25,208
-441
-2% -$43K 0.8% 37
2022
Q1 		$2.6K Buy
25,649
+84
+0.3% +$8.82K 0.5% 35
2021
Q4 		$2.64M Sell
25,565
-117
-0.5% -$10.8K 0.8% 31
2021
Q3 		$2.18M Sell
25,682
-18
-0.1% -$1.51K 0.63% 35
2021
Q2 		$2.14M Buy
25,700
+185
+0.7% +$15.2K 0.72% 38
2021
Q1 		$1.92M Sell
25,515
-344
-1% -$25.1K 0.7% 44
2020
Q4 		$1.77K Sell
25,859
-1,243
-5% -$80.8K 0.28% 43
2020
Q3 		$1.58M Buy
27,102
+237
+0.9% +$14.7K 0.66% 41
2020
Q2 		$1.72M Sell
26,865
-163
-0.6% -$10.3K 0.74% 40
2020
Q1 		$1.64M Buy
27,028
+1,781
+7% +$119K 0.86% 30
2019
Q4 		$1.88K Sell
25,247
-356
-1% -$25K 0.2% 36
2019
Q3 		$1.61M Buy
25,603
+272
+1% +$16.1K 0.76% 34
2019
Q2 		$1.38K Buy
25,331
+870
+4% +$46.9K 0.04% 45
2019
Q1 		$1.32M Buy
24,461
+3,263
+15% +$201K 0.53% 45
2018
Q4 		$1.39K Buy
21,198
+857
+4% +$64K 0.12% 46
2018
Q3 		$1.6M Sell
20,341
-116
-0.6% -$8.29K 0.7% 44
2018
Q2 		$1.32K Buy
20,457
+38
+0.2% +$2.5K 0.09% 46
2018
Q1 		$1.29M Sell
20,419
-2,640
-11% -$189K 0.65% 42
2017
Q4 		$1.67M Sell
23,059
-2,964
-11% -$215K 0.84% 34
2017
Q3 		$2.12M Sell
26,023
-4,537
-15% -$359K 1.13% 22
2017
Q2 		$2.46M Buy
30,560
+198
+0.7% +$15.6K 1.36% 21
2017
Q1 		$23.8K Buy
30,362
+62
+0.2% +$4.95K 10.56% 1
2016
Q4 		$2.39M Buy
30,300
+310
+1% +$25.1K 1.46% 20
2016
Q3 		$2.67M Buy
29,990
+1,934
+7% +$183K 1.68% 17
2016
Q2 		$2.69M Sell
28,056
-356
-1% -$35.5K 1.68% 17
2016
Q1 		$2.95M Buy
28,412
+1,475
+5% +$143K 2.14% 11
2015
Q4 		$2.63M Buy
26,937
+1,225
+5% +$120K 1.86% 12
2015
Q3 		$2.48M Buy
25,712
+727
+3% +$76.4K 1.6% 14
2015
Q2 		$2.62M Sell
24,985
-100
-0.4% -$10.2K 1.89% 12
2015
Q1 		$2.59M Sell
25,085
-1,780
-7% -$180K 1.85% 12
2014
Q4 		$2.59K Sell
26,865
-83
-0.3% -$7.31K 1.55% 12
2014
Q3 		$2.15M Sell
26,948
-187
-0.7% -$14.7K 1.61% 16
2014
Q2 		$2.04K Sell
27,135
-1,517
-5% -$115K 1.16% 25
2014
Q1 		$2.15M Sell
28,652
-242
-0.8% -$17.1K 1.53% 19
2013
Q4 		$2.07K Buy
28,894
+19
+0.1% +$1.22K 0.1% 20
2013
Q3 		$1.64M Buy
28,875
+530
+2% +$31.6K 1.27% 22
2013
Q2 		$1.62K Buy
+28,345
New +$1.64M 0.12% 22

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Newman Dignan & Sheerar Inc's CVS Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its CVS Health (CVS) stake by 0.24% in Q2 2026, selling an estimated $2.23K and leaving 10,424 shares worth $1.08M. The position accounts for 0.21% of the portfolio, ranked #83.

Newman Dignan & Sheerar Inc first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.95M in Q1 2016. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 10,424 shares of CVS Health worth $1.08M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 25 CVS Health shares in Q2 2026, an estimated $2.23K.
  • CVS Health made up 0.21% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #83 holding.
  • Newman Dignan & Sheerar Inc first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Newman Dignan & Sheerar Inc's CVS Health position peaked at $2.95M in Q1 2016.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.